Tela Bio, Inc. (TELA) fundamentals score
Tela Bio is a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its growing product portfolio is purposefully designed to leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 4.6 out of 10, Weak long-term fundamentals
- Growth: 3.6/10
- Profitability: 4.1/10
- Financial health: 2.8/10
- Earnings quality: 7.9/10
- Valuation: 6.4/10
Scores are calculated from Tela Bio, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10